GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medikaloka Hermina Tbk PT HEAL.JK · IDR

Health Care · IDX · 🇮🇩 Indonesia

Compare

488

+1.67%

Close of 9 Nov 2026, in IDR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Medikaloka Hermina Tbk PT

Its shares trade on IDX under the ticker HEAL.JK. It has been listed since 16 May 2018. In the fiscal year to 31 December 2025, it reported revenue of IDR 7.13trn and net income of IDR 429.55bn. At that date it held total assets of IDR 11.89trn and shareholders' equity of IDR 5.68trn.

PT Medikaloka Hermina engages in healthcare services. The company is headquartered in Jakarta Timur, Dki Jakarta. The company went IPO on 2018-05-16. The firm is focused on providing services for BPJS patients to support government program in Indonesia. The Company’s services include hospitals, specialties, and featured services. The Company’s hospitals include Hermina Arcamanik, Hermina Balikpapan, Hermina Banyumanik, Hermina Bekasi, Hermina Bitung, Hermina Bogor, Hermina Ciledug, Hermina Cilegon and Hermina Ciputat. In specialties service, the Company provides anatomical pathology, andrology, anesthesiology, cardiology, clinical microbiology, clinical pathology, dentistry, dermatology and venereology, dietetics, emergency medicine, forensic and medicolegal, internal medicine, medical acupuncture, neurology, and surgery. Its subsidiaries include PT Medikaloka Internusa (M Internusa), PT Medikaloka Sejahtera (M Sejahtera), PT Medikaloka Husada (M Husada), PT Medikaloka Daan Mogot and PT Medikaloka Pasteur (M Pasteur).

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
16 May 2018
Employees
16,099

Leadership

Pay as last reported

  • Dr. Husen SutakariaActing President Commissioner
  • Dr. .. HasmoroPresident Director
  • Dr. Yulisar KhiatVice President Director
  • Dr. Binsar Parasian SimorangkirVice President Director
  • Dr. Tan GunadiDirector
  • Ms. Susi SetiawatyDirector, Company Secretary
  • Mr. Gidion HasanCommissioner
  • Dir. Ir. Darwin NoerhadiCommissioner
  • Ms. Meijani WibowoCommissioner
  • Dr. .. HeridadiIndependent Commissioner
  • Mr. Alexander RusliIndependent Commissioner
  • Dr. Amit VarmaIndependent Commissioner

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Hermina Arcamanik hospital serves 16,099 employees in Jakarta Timur for BPJS patients.
  • M Internusa subsidiary supports government healthcare programs in Indonesia.
  • Hermina Bogor hospital provides specialized services including cardiology and neurology.

Weaknesses

  • Hermina Balikpapan hospital lacks specialty services in anesthesiology and forensic medicine.
  • Hermina Ciledug hospital has limited capacity for emergency medicine services.
  • Hermina Ciputat hospital does not offer dental services or dietetics.

Opportunities

  • Expanding Hermina Banyumanik hospital to serve more BPJS patients in East Java.
  • Introducing medical acupuncture services at Hermina Bekasi hospital.
  • Partnering with M Husada to enhance internal medicine services nationwide.

Threats

  • Hermina Bitung hospital faces competition from local clinics in North Sulawesi.
  • Hermina Cilegon hospital must comply with new healthcare regulations in Indonesia.
  • Hermina Dki Jakarta faces rising operational costs in Jakarta Timur.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.